JME Society for Endocrinology Archive
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Journal of Molecular Endocrinology (1994) 13, 265-273    DOI: 10.1677/jme.0.0130265
© 1994 Society for Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Daffada, A A I
Right arrow Articles by Dowsett, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Daffada, A A I
Right arrow Articles by Dowsett, M

Detection of wild type and exon 5-deleted splice variant oestrogen receptor (ER) mRNA in ER-positive and -negative breast cancer cell lines by reverse transcription/polymerase chain reaction

 A A I Daffada, S R D Johnston, J Nicholls and M Dowsett

Using reverse transcription (RT)/PCR we have shown that four breast cancer cell lines expressed oestrogen receptor (ER) mRNA, irrespective of whether they were assessed as ER-positive (MCF-7 and BT-474) or ER-negative (MDA-MB-231 and BT-20) by enzyme immunoassay (EIA). In addition to the wild type (WT) form, they were all found to express the exon 5-deleted variant (V) form of ER mRNA by RT/PCR; this is thought to code for a truncated constitutively active protein. By Northern blot analysis only the ER-positive cell lines (MCF-7 and BT-474) were found to express detectable levels of ER mRNA. Oestradiol-induced growth was found only in the ER-positive (by EIA) cell lines. These results confirm that the differences between ER-positive and ER-negative cell lines are quantitative rather than qualitative. As low levels of ER mRNA could be detected by RT/PCR, this may reflect the greater sensitivity of this approach. The presence of exon 5-deleted V form ER mRNA in addition to the WT form in all four breast cancer cell lines may allow these lines to be used to assess differential regulation of transcription and the impact of this on their oestrogen dependence.




This article has been cited by other articles:


Home page
 Endocr Relat CancerHome page
N Sarwar, J-S Kim, J Jiang, D Peston, H D Sinnett, P Madden, J M Gee, R I Nicholson, A E Lykkesfeldt, S Shousha, et al.
Phosphorylation of ER{alpha} at serine 118 in primary breast cancer and in tamoxifen-resistant tumours is indicative of a complex role for ER{alpha} phosphorylation in breast cancer progression.
Endocr. Relat. Cancer, September 1, 2006; 13(3): 851 - 861.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
E. Leygue, H. Dotzlaw, P. H. Watson, and L. C. Murphy
Expression of the Steroid Receptor RNA Activator in Human Breast Tumors
Cancer Res., September 1, 1999; 59(17): 4190 - 4193.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. L. Balleine, S. M. N. Hunt, and C. L. Clarke
Coexpression of Alternatively Spliced Estrogen and Progesterone Receptor Transcripts in Human Breast Cancer
J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1370 - 1377.
[Abstract] [Full Text]

Home page
 Mol. Endocrinol.Home page
I. Erenburg, B. Schachter, R. M. y Lopez, and L. Ossowski
Loss of an Estrogen Receptor Isoform (ER{alpha}{Delta}3) in Breast Cancer and the Consequences of Its Reexpression: Interference with Estrogen-Stimulated Properties of Malignant Transformation
Mol. Endocrinol., December 1, 1997; 11(13): 2004 - 2015.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the Society for Endocrinology.